Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast CancerHER2-positive Metastatic Breast CancerRecruitingNot stated2026-07-08NCT06551116

3 results · Page 1 of 1

Swipe the table sideways for more columns.

37 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Abramson Cancer Center of the University of PennsylvaniaPhiladelphiaUnited States47
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer CenterHoustonUnited States1
Ben Taub General HospitalHoustonUnited States65
Georgetown University - Lombardi CCCWashington D.C.United States1
John's Hopkins HospitalBaltimoreUnited States1
MD Anderson Cancer CenterHoustonUnited States589
MD Anderson Cancer CenterSugar LandUnited States1
MD Anderson Cancer centerLeague CityUnited States1
MD Anderson Cancer CenterHoustonUnited States1
MD Anderson Cancer centerWoodlandUnited States1
MedStar Washington Hospital CenterWashington D.C.United States207
Montefiore Einstein Medical CenterThe BronxUnited States3
Penn Medicine Princeton Medical CenterPlainsboroUnited States2
Sibley Memorial HospitalWashington D.C.United States121
Smilow Cancer Hospital at GlastonburyGlastonburyUnited States2
Smilow Cancer Hospital at Saint FrancisHartfordUnited States3
Smilow Cancer Hospital Care CenterTrumbullUnited States1
Smilow Cancer Hospital Care CenterGuilfordUnited States1
Smilow Cancer Hospital Care CenterFairfieldUnited States1
Smilow Cancer Hospital Care CenterWesterlyUnited States1
Smilow Cancer Hospital Care Center - WaterfordWaterfordUnited States103
Smilow Cancer Hospital Care Center at GreenwichGreenwichUnited States78
Smilow Cancer Hospital Care Center at Long RidgeStamfordUnited States1
Smilow Cancer Hospital-Derby Care CenterDerbyUnited States92
Smilow Cancer Hospital-Torrington Care CenterTorringtonUnited States90